TUCSON, Ariz. — Detectives hunting for Nancy Guthrie have been handed their most “promising” lead yet, a former top cop told The Post — after Walmart handed over purchase records that could finally ...
Investigators working on the disappearance of "Today" show host Savannah Guthrie's mother are consulting with Walmart management to develop leads because a backpack the suspect was wearing is sold ...
TUCSON, Ariz. — A single backpack has become a critical focal point in the investigation into Nancy Guthrie’s disappearance, prompting federal authorities to comb through Walmart sales records and ...
SAN FRANCISCO -- One new startup is called Recursive with an "e." Another is called Ricursive with an "i." They are trying to do the same thing: Build artificial intelligence that can improve itself ...
Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...
Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...
Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...
Like everyone else, I’ve amassed quite the collection of totes over the years. But aside from using one to carry things from my house to the beach several years ago, I never really saw the appeal of ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...